NP
REGN icon

Nilsine Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Nilsine Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$916K Sell
1,469
-2
-0.1% -$1.36K 0.06% 241
2026
Q1 		$1.1M Sell
1,471
-113
-7% -$86.5K 0.09% 201
2025
Q4 		$1.22M Sell
1,584
-8
-0.5% -$5.43K 0.11% 188
2025
Q3 		$895K Buy
1,592
+7
+0.4% +$3.96K 0.08% 220
2025
Q2 		$832K Buy
1,585
+239
+18% +$133K 0.08% 217
2025
Q1 		$854K Buy
1,346
+340
+34% +$234K 0.09% 199
2024
Q4 		$717K Buy
1,006
+27
+3% +$22.7K 0.08% 214
2024
Q3 		$1.03M Sell
979
-72
-7% -$80.1K 0.13% 173
2024
Q2 		$1.1M Sell
1,051
-131
-11% -$127K 0.15% 158
2024
Q1 		$1.14M Buy
1,182
+23
+2% +$21.9K 0.16% 156
2023
Q4 		$1.02M Sell
1,159
-258
-18% -$212K 0.16% 161
2023
Q3 		$1.17M Buy
1,417
+6
+0.4% +$4.71K 0.18% 142
2023
Q2 		$1.01M Buy
1,411
+8
+0.6% +$6.17K 0.15% 165
2023
Q1 		$1.15M Buy
+1,403
New +$1.06M 0.18% 149

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Nilsine Partners's REGN Position: Q2 2026 in Review

Nilsine Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 0.14% in Q2 2026, selling an estimated $1.36K and leaving 1,469 shares worth $916K. The position accounts for 0.06% of the portfolio, ranked #241.

Nilsine Partners first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Nilsine Partners held 1,469 shares of Regeneron Pharmaceuticals worth $916K as of Q2 2026.
  • Nilsine Partners sold 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
  • Regeneron Pharmaceuticals made up 0.06% of Nilsine Partners's portfolio in Q2 2026, its #241 holding.
  • Nilsine Partners first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Regeneron Pharmaceuticals position peaked at $1.22M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.